Market Research Reports and Industry Reports

Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] Global Forecast to 2019

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The global intrauterine contraceptive devices market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing the expenses related to abortion, funds/grants for IUCD products, and technological advancements.
 
 However, high cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications during unplanned pregnancy, and need of compulsory assistance of medical professional is hampering the growth of IUCD market. Moreover, rising number of players in this segment, technological advancements are creating growth opportunities for the global intrauterine contraceptive devices market.
 
 In this report, the market has been broadly classified on the basis of types which includes; Hormonal IUCD and Copper IUCD. The copper IUCD market segment is accounted for the largest market share of 51.9%.
 
 Geographically, the market in Asia accounted for the largest share of 35.0% of the Global Intrauterine Contraceptive Devices market in 2014, followed by Europe. The Intrauterine Contraceptive Devices market in the U.S. is primarily driven by Affordable Care Act, technological advancements. However, stringent regulatory and reimbursement policies in U.S., threat to PID infection are hampering the growth of the Intrauterine Contraceptive Devices market in this region.
 
 The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to strengthen their position in this market.
 
 Reasons to Buy the Report:
 

 From an insight perspective, this research report has focused on various levels of analysis—, market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the global intrauterine contraceptive devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
 
 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
 
 The report provides insights on the following pointers:
 

 • Market Penetration: Comprehensive information on Intrauterine Contraceptive Devices offered by the top players in the Global Intrauterine Contraceptive Devices market
 
 • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Intrauterine Contraceptive Devices market.
 
 • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Intrauterine Contraceptive Devices across geographies.
 
 • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Global Intrauterine Contraceptive Devices market.
 • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Global Intrauterine Contraceptive Devices market.

1 INTRODUCTION 8
 1.1 OBJECTIVES OF THE STUDY 9
 1.2 MARKET SEGMENTATION & COVERAGE 10
 
 2 RESEARCH METHODOLOGY 11
 2.1 INTEGRATED ECOSYSTEM OF INTRAUTERINE CONTRACEPTIVE DEVICES MARKET 12
 2.2 ARRIVING AT THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE 13
 2.2.1 TOP-DOWN APPROACH 13
 2.2.2 BOTTOM-UP APPROACH 14
 2.2.3 MACRO INDICATOR-BASED APPROACH 15
 2.3 ASSUMPTIONS 16
 
 3 EXECUTIVE SUMMARY 17
 
 4 MARKET OVERVIEW 19
 4.1 INTRODUCTION 19
 4.2 MARKET DRIVERS AND INHIBITORS 20
 4.3 KEY MARKET DYNAMICS 23
 
 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 26
 5.1 INTRODUCTION 27
 5.2 COPPER IUD 27
 5.3 HORMONAL IUD 28
 5.4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET 29
 5.5 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY 31
 5.6 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY 32
 
 6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT 33
 6.1 MIRENA 33
 6.1.1 PRODUCT POSITIONING AND PROMOTIONS OF MIRENA 34
 6.2 SKYLA 35
 6.2.1 PRODUCT POSITIONING AND PROMOTIONS OF SKYLA 35
 6.3 PARAGARD 36
 6.3.1 PRODUCT POSITIONING AND PROMOTIONS OF PARAGARD 37
 6.4 ESSURE 38
 6.4.1 PRODUCT POSITIONING AND PROMOTIONS OF ESSURE 38
 6.5 PIPELINE PRODUCTS 39
 6.5.1 LEVOSERT 40
 
 7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 41
 7.1 INTRODUCTION 42
 7.2 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET 43
 7.3 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 47
 7.4 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 51
 7.5 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55
 
 8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE 59
 8.1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS 59
 8.2 MERGERS & ACQUISITIONS 60
 8.3 REGULATORY APPROVALS 60
 8.4 PARTNERSHIP 61
 8.5 COLLABORATION 61
 
 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COMPANY 62
 (Overview, Financials, Products & Services, Strategy, and Developments)*
 9.1 BAYER HEALTHCARE AG (SUBSIDIARY OF BAYER AG) 62
 9.2 TEVA PHARMACEUTICAL INDUSTRIES LTD. 66
 9.3 ACTAVIS PLC 69
 9.4 MEDICINE360 71
 9.5 TRIMEDIC SUPPLY NETWORK LTD. 72
 9.6 MEDISAFE DISTRIBUTION INC. 73
 9.7 PACE PHARMACEUTICALS, INC. 74
 9.8 SMB CORPORATION 75
 9.9 OCON MEDICAL LTD. 76
 *Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
 
 10 APPENDIX 77
 10.1 RELATED REPORTS 77
 10.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 78
 10.2.1 RT SNAPSHOTS 79


List Of Tables

TABLE 1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: MACRO INDICATORS, BY REGION, 2008 (ABORTION PER 1000 WOMEN AGES 15-44) 16
 TABLE 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: DRIVERS AND INHIBITORS 20
 TABLE 3 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPARISON WITH GLOBAL FEMALE CONTRACEPTIVES MARKET, 2013 - 2019 (USD MN) 24
 TABLE 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
 2013 - 2019 (USD MN) 24
 TABLE 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
 2013 - 2019 (USD MN) 25
 TABLE 6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET, 2013–2019 (USD MN) 30
 TABLE 7 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 31
 TABLE 8 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 32
 TABLE 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY ,
 2013 - 2019 (USD MN) 42
 TABLE 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
 2013 -2019 (USD MN) 42
 TABLE 11 ASIA :INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
 2013-2019 (USD MN) 43
 TABLE 12 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
 2013-2019 (USD MN) 44
 TABLE 13 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY,
 2013-2019 (USD MN) 47
 TABLE 14 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 48
 TABLE 15 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
 BY GEOGRAPHY 51
 TABLE 16 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 52
 TABLE 17 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55
 TABLE 18 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 56
 TABLE 19 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 59
 TABLE 20 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET:
 MERGERS & ACQUISITIONS 60
 TABLE 21 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: REGULATORY APPROVALS 60
 TABLE 22 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: PARTNERSHIP 61
 TABLE 23 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COLLABORATION 61
 TABLE 24 BAYER HEALTHCARE AG.: KEY FINANCIALS, 2008 - 2013 (USD MN) 63
 TABLE 25 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS, 2008 - 2013 (USD MN) 66
 TABLE 26 ACTAVIS PLC: KEY FINANCIALS, 2008 - 2013 (USD MN) 69


List Of Figures

FIGURE 1 EVOLUTION OF INTRAUTERINE CONTRACEPTIVE DEVICES (IUD/IUCD) 8
 FIGURE 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET:
 SEGMENTATION & COVERAGE 10
 FIGURE 3 INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: INTEGRATED ECOSYSTEM 12
 FIGURE 4 TOP-DOWN APPROACH 14
 FIGURE 5 BOTTOM-UP APPROACH 15
 FIGURE 6 MACRO INDICATOR-BASED APPROACH 15
 FIGURE 7 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SNAPSHOT 18
 FIGURE 8 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPARISON WITH GLOBAL FEMALE CONTRACEPTIVES MARKET 23
 FIGURE 9 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES, BY REGION,
 2014 & 2019 (USD MN) 24
 FIGURE 10 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
 2014 & 2019 (USD MN) 25
 FIGURE 11 ADVANTAGES & DISADVANTAGES OF COPPER IUD 27
 FIGURE 12 ADVANTAGES & DISADVANTAGES OF HORMONAL IUD 28
 FIGURE 13 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE,
 2012 - 2018 (USD MN) 29
 FIGURE 14 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET, 2013–2019 (USD MN) 29
 FIGURE 15 GLOBAL COPPER IUD MARKET, BY GEOGRAPHY , 2013 - 2019 (USD MN) 31
 FIGURE 16 GLOBAL HORMONAL IUD MARKET, BY GEOGRAPHY, 2013 - 2019 (USD MN) 32
 FIGURE 17 ADVERSE EFFECTS CAUSED BY MIRENA, U.S., 1997-2012 34
 FIGURE 18 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 43
 FIGURE 19 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 44
 FIGURE 20 ASIA: INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 45
 FIGURE 21 ASIA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPECOMPARISION WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 45
 FIGURE 22 ASIA : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 46
 FIGURE 23 ASIA: HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 46
 FIGURE 24 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 47
 FIGURE 25 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 48
 FIGURE 26 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 49
 FIGURE 27 EUROPE : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPE COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 49
 FIGURE 28 EUROPE : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 50
 FIGURE 29 EUROPE : HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
 (2013-2019) 50
 FIGURE 30 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
 BY GEOGRAPHY 51
 FIGURE 31 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 52
 FIGURE 32 NORTH AMERICA : INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 53
 FIGURE 33 NORTH AMERICA :INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPES COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 53
 FIGURE 34 NORTH AMERICA : HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 54
 FIGURE 35 NORTH AMERICA : COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET,
 (2013-2019) 54
 FIGURE 36 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY 55
 FIGURE 37 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 56
 FIGURE 38 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPES 57
 FIGURE 39 ROW INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: BY TYPES COMPARISON WITH FEMALE CONTRACEPTIVE DEVICES MARKET (2013-2019) 57
 FIGURE 40 ROW HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2013-2019 58
 FIGURE 41 ROW COPPER INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, (2013-2019) 58
 FIGURE 42 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 59
 FIGURE 43 BAYER HEALTHCARE AG: REVENUE MIX (2013) (%) 62
 FIGURE 44 CONTRIBUTION OF PHARMACEUTICALS SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN) 63
 FIGURE 45 TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE MIX (2013) (%) 66
 FIGURE 46 CONTRIBUTION OF SPECIALITY MEDICINE SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN) 67
 FIGURE 47 ACTAVIS PLC: REVENUE MIX (2013) (%) 69


Global Intrauterine Device Industry 2015 Market Research Report

The Global Intrauterine Device Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Intrauterine Device industry.The report provides a basic overview of

USD 2800View Report

Global Intrauterine Devices Industry 2015 Market Research Report

The Global Intrauterine Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Intrauterine Devices industry.The report provides a basic overview of

USD 2800View Report

United States Intrauterine Devices Industry 2015 Market Research Report

The United States Intrauterine Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Intrauterine Devices industry.The report provides a basic overview

USD 3800View Report

Global Contraceptive Devices Consumption 2016 Market Research Report

The Global Contraceptive Devices Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Contraceptive Devices market.First, the report provides a basic overview

USD 4000View Report

United States Intrauterine Contraceptive Devices Industry Report 2015

The United States Intrauterine Contraceptive Devices Industry Report 2015 is a professional and in-depth study on the current state of the Intrauterine Contraceptive Devices industry. The report provides a

USD 3800View Report

Global Contraceptive Devices Industry 2015 Market Research Report

The Global Contraceptive Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Contraceptive Devices industry.    The report provides a basic

USD 2800View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4250
  • Corporate Licence    $ 7225
$ 4250

Reports Details

Published Date : Apr 2015
No. of Pages :80
Country :Global
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment